Advertisement

Topics

PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Company First in Industry to Achieve This Milestone

08:30 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Innovative Biotech Company Adopts Medidata Rave EDC, Benefiting From a Unified Platform for All Phases of the Study Biotech company, PhaseBio Pharmaceuticals, has become Medidata’s (NASDAQ:MDSO) 1,000th customer. Medidata ...

Other Sources for this Article

Medidata:
Investor:
Medidata Solutions
Betsy Frank, +1 917-522-4620
bfrank@mdsol.com
or
Media:
Medidata Solutions
Erik Snider, +1 646-362-2997
esnider@mdsol.com

NEXT ARTICLE

More From BioPortfolio on "PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Company First in Industry to Achieve This Milestone"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...